FORA Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
+5,520
| New | +$1.21M | 0.13% | 190 |
|
|
2024
Q4 | – | Sell |
-8,498
| Closed | -$2.55M | – | 622 |
|
|
2024
Q3 | $2.55M | Buy |
8,498
+7,789
| +1,099% | +$2.34M | 0.3% | 98 |
|
|
2024
Q2 | $234K | Buy |
+709
| New | +$234K | 0.03% | 341 |
|
|
2024
Q1 | – | Sell |
-6,837
| Closed | -$2.41M | – | 590 |
|
|
2023
Q4 | $2.41M | Buy |
6,837
+3,928
| +135% | +$1.38M | 0.21% | 135 |
|
|
2023
Q3 | $1.09M | Sell |
2,909
-5,917
| -67% | -$2.22M | 0.1% | 235 |
|
|
2023
Q2 | $3.38M | Buy |
+8,826
| New | +$3.38M | 0.48% | 63 |
|
|
2022
Q3 | – | Sell |
-4,298
| Closed | -$1.3M | – | 605 |
|
|
2022
Q2 | $1.3M | Buy |
4,298
+3,688
| +605% | +$1.12M | 0.26% | 125 |
|
|
2022
Q1 | $255K | Buy |
610
+149
| +32% | +$62.3K | 0.05% | 428 |
|
|
2021
Q4 | $216K | Sell |
461
-200
| -30% | -$93.7K | 0.08% | 280 |
|
|
2021
Q3 | $281K | Sell |
661
-1,486
| -69% | -$632K | 0.07% | 290 |
|
|
2021
Q2 | $771K | Buy |
2,147
+1,596
| +290% | +$573K | 0.14% | 182 |
|
|
2021
Q1 | $155K | Buy |
+551
| New | +$155K | 0.05% | 331 |
|
|
2020
Q2 | – | Sell |
-6,001
| Closed | -$914K | – | 1363 |
|
|
2020
Q1 | $914K | Buy |
6,001
+3,333
| +125% | +$508K | 0.2% | 135 |
|
|
2019
Q4 | $401K | Buy |
+2,668
| New | +$401K | 0.04% | 448 |
|